What's New in Weight Loss 2026: Pills, Higher Doses, and Emerging GLP-1 Therapies Explore the latest developments in weight management for 2026, including the Wegovy oral pill, 7.2mg Wegovy injections, and emerging GLP-1 and triple-agonist therapies
As part of our dedication to offering thorough, individualized medical weight loss programs, we stay abreast of the latest developments in medical research, including the potential uses of medications like GLP-1 agonists for managing type 2 diabetes and aiding in weight loss
Gastaldelli A, Cusi K, Fernandez Lando L, Bray R, Brouwers B, Rodriguez A
doi:10.1016/j.peptides.2019.170213 318
Though again, you may be able to pay as little as $25 for a month, depending on your insurance
Patients should verify their plan's HSA/FSA eligibility rules with their plan administrators